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AbstrACt
It is common to undertake qualitative research alongside 
randomised controlled trials (RCTs) when evaluating 
complex interventions. Researchers tend to analyse these 
datasets one by one and then consider their findings 
separately within the discussion section of the final report, 
rarely integrating quantitative and qualitative data or 
findings, and missing opportunities to combine data in 
order to add rigour, enabling thorough and more complete 
analysis, provide credibility to results, and generate further 
important insights about the intervention under evaluation. 
This paper reports on a 2 day expert meeting funded by the 
United Kingdom Medical Research Council Hubs for Trials 
Methodology Research with the aims to identify current 
strengths and weaknesses in the integration of quantitative 
and qualitative methods in clinical trials, establish the 
next steps required to provide the trials community with 
guidance on the integration of mixed methods in RCTs and 
set- up a network of individuals, groups and organisations 
willing to collaborate on related methodological activity. 
We summarise integration techniques and go beyond 
previous publications by highlighting the potential value 
of integration using three examples that are specific to 
RCTs. We suggest that applying mixed methods integration 
techniques to data or findings from studies involving both 
RCTs and qualitative research can yield insights that might 
be useful for understanding variation in outcomes, the 
mechanism by which interventions have an impact, and 
identifying ways of tailoring therapy to patient preference 
and type. Given a general lack of examples and knowledge 
of these techniques, researchers and funders will need 
future guidance on how to undertake and appraise them.
bACkground
It is common to undertake qualitative 
research alongside randomised controlled 
trials (RCTs) when evaluating complex inter-
ventions.1 2 Qualitative research can be used 
to explore the feasibility, acceptability and 
implementation of an intervention to help 
understand how it was effective or why it was 
not effective within the RCT, or to explore 
the conduct of the RCT to help improve 
recruitment or retention rates.2 Qualitative 
research can be undertaken as part of a mixed 
methods process evaluation,3 as a qualitative 
process evaluation, or as an embedded quali-
tative study alongside a fully powered or pilot 
RCT.4 In studies like this, researchers have a 
number of datasets to analyse: outcome data 
from the RCT, quantitative process data, and 
qualitative process data. Researchers tend to 
analyse these datasets separately and then 
consider their findings separately within 
the discussion section of the final report to 
funders. Researchers rarely integrate quanti-
tative and qualitative data or findings,1 or use 
formal analytical techniques recommended 
within wider mixed methods research. This 
may be because researchers are not aware of 
existing integration techniques or do not see 
the value of these techniques to the context 
of RCTs. Unfortunately, they may be missing 
opportunities to fully use data that has 
taken years to collect at great cost that could 
generate further important insights about the 
intervention under evaluation.
Aims
In 2017, 20 researchers who generate evidence 
on the effectiveness of health interventions 
in healthcare and public health, and/or 
who have written methodological articles 
on integration in mixed methods research, 
came together in a 2 day meeting funded 
by the United Kingdom Medical Research 
Council Hubs for Trials Methodology 
Research. The aims of the meeting were to: 
i) identify current strengths and weaknesses 
in the integration of quantitative and quali-
tative methods in clinical trials; ii) establish 
the next steps required to provide the trials 
community with guidance on the integration 
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of mixed methods in RCTs; iii) set- up a network of indi-
viduals, groups and organisations willing to collaborate 
on related methodological activity.
The meeting was structured in the form of a summit 
(day 1) and expert panel (day 2) with pre- circulated 
agenda topics. The summit was focused on current 
strengths and weaknesses in the integration of quanti-
tative and qualitative trial data including presentations 
from leading experts on integration and clinical trials, 
mixed methods analyses, mixed methods study designs, 
and writing mixed methods grant applications and study 
reports. Each topic was followed by facilitated small group 
discussions with focused questions for each group. These 
outputs were summarised and presented to the whole 
group on day two where the expert panel considered the 
need for guidance on the analytic integration of quantita-
tive and qualitative trial data and the next steps required 
to produce it. Delegates also discussed the writing of a 
position paper, publication plans and future collabora-
tion networks.
In this paper, the attendees at that meeting summarise 
relevant integration techniques, describe the key conclu-
sions drawn, and propose the potential value of integra-
tion using three examples of integration suggested by 
the expert panel in the context of both pilot and fully 
powered RCTs. The focus is on RCTs of health interven-
tions but the paper is likely to be relevant to RCTs in other 
fields such as education and social care.
summary of integration techniques
The term integration is used to describe an intentional 
process whereby researchers use quantitative and qual-
itative data or findings interdependently to address a 
common goal. Mixed methods researchers have described 
a range of integration techniques.5–9 One key integration 
technique is joint displays that involve the production of 
a figure, table or graph to juxtapose and compare quan-
titative and qualitative data or findings. Other techniques 
can compare the qualitative responses of participants 
based on their measured response to the trial, or create 
a consolidated database drawing on both quantitative 
and (transformed) qualitative data for further statistical 
analysis.
meeting conclusions: the need for examples and guidance
Having listened to discussions about integration in 
mixed methods research, and considered its role in the 
context of RCTs, attendees concluded that integration 
rarely occurs in practice, that there is much to be learnt 
from integration techniques from wider mixed methods 
research, and that an important step is to communicate 
the potential value of integration to the research commu-
nity through relevant examples. Once researchers see 
evidence of value, in terms of this practice generating 
credible new and useful insights, formal guidance could 
be developed to ensure the quality of this endeavour. 
Such guidance could include systematic reviews of the 
utility of different methods used for mixed methods data 
integration with decision aids to help researchers make 
decisions about the most appropriate approach to adopt 
in different circumstances, how to ensure that the poten-
tial for data integration is factored into trial design at 
the earliest possible stages, the meaning of credibility for 
integrative practices, and how reviewers, funding boards, 
and readers can make judgments about the credibility 
of integration. Attendees agreed that in common with 
other clinical guidance documents, concrete examples 
of where these techniques have been used are required 
as part of the guideline. However, attendees struggled to 
identify many published examples of integration under-
taken in the context of RCTs.
Examples of the potential value of integration in the context 
of rCts
Three examples were nonetheless identified and 
suggested by participants, and are described below. These 
examples integrate data or findings in the context of 
pilot or fully powered RCTs, and use various approaches 
to data integration and synthesis, guided by quantitative 
and/or qualitative data.
Example 1: integrating findings from a pilot rCt and 
embedded qualitative interview study to develop insights 
about treatment responses
Thirty- one cancer patients took part in a cross- over pilot 
RCT of music medicine compared with music therapy.10 
Music medicine consisted of two sessions of listening to 
pre- recorded music; music therapy involved two sessions 
of interactive music- making with a music therapist. 
Before and after each session participants rated their 
mood, anxiety, relaxation and pain; 30 participants also 
completed a qualitative interview at the end of treatment. 
The quantitative pre- post change in outcomes and qual-
itative interview data of experiences were analysed sepa-
rately. Findings were then integrated to explore why some 
individual patients appeared to benefit more from one 
intervention than the other. As a pilot RCT the study did 
not have sufficient statistical power to detect clinically 
meaningful differences in the effectiveness of these treat-
ments, should such differences exist, but the study quan-
titative findings were that participants’ mood, anxiety, 
relaxation and pain appeared to improve following either 
music medicine or music therapy. The findings from 
the qualitative interviews were that patients experienced 
music medicine and music therapy as relaxing and fun. 
Participants escaped from stress in general and worries 
related to cancer in particular. Music also offered hope for 
the future. In addition, music therapy enabled patients to 
be creative and the presence of a therapist helped some 
patients to release emotion. Other patients felt more 
comfortable with music medicine because there was no 
therapist and because they could listen to familiar music.
Findings were integrated during the analysis phase of 
the study to explore reasons for variation in outcomes. 
The researchers did this by creating a joint display of 
quantitative and qualitative findings for four groups of 
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Figure 1 Joint display table summarising findings from RCT and qualitative research (Bradt J, Potvin N, Kesslick a et al. 
supportive care in cancer 2015,10 reproduced with permission).
the 30 patients with both qualitative and quantitative 
data: participants who showed quantitative (a) improve-
ment following music therapy (MT) but much less or 
no improvement following music medicine (MM) (b) 
improvement following MM but much less or no improve-
ment following MT, (c) improvement following both 
interventions, and (d) deterioration following both inter-
ventions. Improvement or deterioration was determined 
based on z- scores for changes in mood, anxiety, relaxation 
and pain for each patient. Patient experiences, expressed 
in the qualitative interviews, were summarised in the table 
for each of the four groups. These experiences differed by 
each of the four groups. Patients who described valuing 
the therapeutic relationship and creative elements of 
making music in the qualitative research benefited more 
from MT than MM. Patients who were apprehensive about 
active music making and exploring feelings related to 
cancer benefited more from MM than MT (see figure 1).
Integration of findings from independent quantitative 
and qualitative analyses identified that participant pref-
erences and attitudes appeared to impact on treatment 
benefits. This generates the hypothesis that an effective 
intervention could be one where cancer patients are offered 
a choice of music therapy or music medicine based on their 
preferences. This hypothesis could then be tested in a fully 
powered RCT. This approach to analysis is not without chal-
lenges. Although blinding of qualitative researchers is often 
thought to be highly difficult because of the nature of the 
researcher/participant conversations, with careful organi-
sation it is possible do initial analyses blind to knowledge 
of the other, for example by analysing qualitative findings 
not knowing the trial outcomes, generating key finding 
statements from each dataset still blind. Blinding of mixed 
methods analysts to the quantitatively determined group 
allocations may be difficult but would be desirable during 
integration to further reduce the potential for analytical 
bias. Despite organisational difficulties, however, there is 
the potential for this technique to identify new insights 
about variation in outcomes and how to develop interven-
tions to address them.
Example 2: integrating data from a pilot rCt and qualitative 
process data to develop insights about treatment adherence 
and outcomes
Sixty- eight adults with depression participated in a pilot 
RCT of Morita Therapy plus Treatment As Usual (TAU) 
vs TAU alone.11 Morita Therapy is a Japanese psycho-
logical therapy for common mental health problems 
where patients are taught that unpleasant thoughts and 
emotions ebb and flow as a matter of course, cannot be 
controlled by will, and can be accepted as part of the 
natural ecology of the human experience. Twenty- eight 
intervention participants also attended a post- treatment 
qualitative interview.12 Following separate analysis of the 
RCT data and the qualitative interviews, data from the 
interviews and pilot RCT were integrated at the level of 
individual participants who had provided both types of 
data to explore how participants’ views of the interven-
tion related to the number of sessions they attended and 
whether they responded to treatment. Morita Therapy 
participants attended a mean of 8 treatment sessions out 
of a maximum of 12; 24/34 (70.6%) adhered to a per- 
protocol minimum dose (≥5 sessions). The pilot RCT was 
not powered to detect clinically meaningful differences in 
treatment effectiveness; however, at follow- up 22/33 inter-
vention participants (66.7%) scored below the threshold 
for major depressive disorder on a depression symptom 
checklist compared with 13.3% of controls. During the 
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qualitative interviews, many but not all of those receiving 
Morita Therapy found it acceptable. Acceptability was 
related to participants’ expectations and understandings 
of treatment (or ‘orientation’ towards treatment) being 
compatible or not with the principles of Morita Therapy. 
Participants distinguished between engaging with Morita 
Therapy on a conceptual level and engaging with it on a 
practical level such as finding the required time to do it.
Quantitative and qualitative data were then integrated 
for individual intervention participants. Qualitative 
data were organised into typologies of views on Morita 
Therapy, according to the extent to which participants 
found (1) the principles and (2) the practical processes 
of the therapy acceptable. Quantitative data from the 
RCT on the numbers of sessions attended and the clin-
ical outcomes were added into a joint display. Participants 
who identified with Morita Therapy principles typically 
responded to treatment regardless of the number of 
sessions they attended; conversely, those whose orienta-
tion towards treatment was incompatible with the inter-
vention did not respond to treatment, again regardless 
of treatment adherence. Participants whose personal 
circumstances (such as a lack of time or support from 
others) impeded their opportunity to engage in the inter-
vention generally attended the fewest number of sessions 
but this did not drive clinical outcome.
By integrating qualitative and quantitative data the 
possibility of new relationships between orientation 
towards treatment, adherence and clinical outcomes 
were found. These suggested that personalising depres-
sion treatment by choosing an approach (for example, 
“Western” or “Eastern” treatment, directive or non- 
directive approaches) according to the extent to which 
the conceptual underpinnings of that treatment were 
compatible with a person’s own worldview, could lead to 
better individual outcomes. It also raised the possibility 
that, where this congruence is present, patients with 
demanding personal circumstances which constrain their 
ability to engage in treatment may still benefit from a 
lower intensity version of the same treatment offered in 
fewer sessions. Clearly the small numbers in this study is a 
limitation and the analysis was not conclusive, but rather 
they raised interesting possibilities for testing in future 
RCTs of personalised medicine.
Example 3: integrating findings from the quantitative and 
qualitative parts of a process evaluation to interpret the 
findings of a fully powered cluster rCt
A large, multi- country factorial cluster RCT was conducted 
to examine the effectiveness of interventions aimed 
at decreasing antibiotic prescribing for acute cough by 
general practitioners (GPs).13 Interventions were: (i) 
GP communication skills training and use of a patient 
booklet; (ii) training in the provision and use of a C- re-
active protein (CRP) test device; (iii) both interventions; 
or (iv) neither intervention. Each of the separate inter-
ventions led to decreases in antibiotic prescribing and 
the combination of both led to the largest decrease. The 
mixed methods process evaluation, undertaken along-
side the RCT, collected quantitative and qualitative data 
on patients’ and GPs’ views on prescribing antibiotics for 
acute cough and their experiences of the interventions. 
Quantitative self- report data were collected from 2886 
patients and 346 GPs. Qualitative data were collected 
from interviews with 62 patients and 66 GPs. Data from 
the four different sources in the process evaluation were 
analysed separately. Findings from all four sources were 
then compared in an integrative analysis.14 Based on the 
surveys, there was a high level of satisfaction with both 
interventions. GPs reported that the communication 
skills training, use of a patient booklet, and training with 
use of the CRP test helped them to reduce prescribing. 
Patients who received the booklet reported the highest 
levels of self- care enablement for their cough and aware-
ness that taking antibiotics could be risky and harmful. 
Based on the qualitative interviews, GPs felt that the 
communication skills training gave them greater confi-
dence in addressing patient expectations for an antibiotic 
and that the CRP test was helpful to decrease diagnostic 
uncertainty and reassure patients. The booklet and use 
of the CRP test were acceptable to patients and patients 
perceived that both the interventions supported GPs’ 
prescribing decision.
The key findings from each of the four datasets in 
the process evaluation were integrated by summarising 
them in a form of joint display known as Triangulation 
Protocol.15 Three analysts independently compared find-
ings across the datasets, considering where they agreed, 
partly agreed, did not agree, or where there was an unex-
pected gap in findings from one of the datasets. Examples 
of the joint displays are given within the article. There 
was disagreement between findings from different data-
sets in terms of the utility of the CRP test. In the qual-
itative interviews with GPs, the CRP test was viewed as 
helping to convince patients that a no- antibiotic decision 
was appropriate when the patient expected an antibiotic 
to be prescribed. In contrast, patients reported in inter-
views that they were confident in the GP’s prescription 
decision regardless of whether or not the CRP test had 
been undertaken, especially if they were given a detailed 
explanation by their GP and a booklet on self- care. 
Findings from the patient survey reinforced the impor-
tance of communication to patients. This highlighted 
the importance to patients of improved communication 
rather than diagnostics for antibiotic prescribing. Limita-
tions included the non- complementary nature of the 
retrospectively designed interview guides and the lack of 
individual participant level data linking. This study also 
highlighted that attention needs to be paid to the quality 
of the application of integration techniques, for example 
the use of three independent analysts to create and inter-
pret the joint display.
ConClusions
Applying mixed methods integration techniques to 
data or findings from studies involving both RCTs and 
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qualitative research can yield insights that might be useful 
for understanding variation in outcomes, the mechanism 
by which interventions have an impact, and identifying 
ways of tailoring therapy to patient preference and type. 
The three examples given here are by no means defini-
tive. However, they do illustrate different approaches to 
data integration including synthesis of findings driven by 
quantitative data (example 1), qualitative data (example 
2), or by both equally (example 3). Further examples of 
integration using these and other analytical techniques 
might help to persuade researchers and funders of the 
value of doing this. However, published examples remain 
rare and the research community has no guidance on 
which of these and other techniques might yield the best 
added value to RCTs. The development of guidance will 
help to ensure the quality of this practice by, for example, 
recommending the use of independent data collection 
and analysis, blinding of analysts undertaking integration 
analyses, and rationale for the choice of analysis methods. 
Such guidance could include systematic reviews of the 
utility of different methods used for mixed methods data 
integration with decision aids to help. Guidance might 
also equip research funding boards, reviewers and other 
readers to judge the credibility of any integration.
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